HomeNewsTrendsThis test package promises faster and better diagnosis of PCOS in women

This test package promises faster and better diagnosis of PCOS in women

Polycystic ovary syndrome is a common endocrine disorder predominantly affecting women of reproductive age. Clinical manifestations are diverse, including overproduction of some male hormones, lack of ovulation, infertility, hair loss and increased risk of metabolic diseases, besides psychosocial dysfunction

November 11, 2022 / 09:51 IST
Story continues below Advertisement
Representative Image
Representative Image

Diagnosing polycystic ovary syndrome (PCOS), one of the commonest chronic hormonal conditions in women, has become easier with Veera Health, a major digital therapeutics platform for managing the ailment, collaborating with Tata 1mg to offer a first-of-its-kind comprehensive test package.

The traditional routes for PCOS testing are fragmented. Most women find themselves hopping between clinics and being asked to test for a number of different clinical criteria, most of which may be totally unnecessary for a diagnosis.

Story continues below Advertisement

“We’ve solved this problem by launching a package that tests for all essential biomarkers to diagnose PCOS,” said Shashwata Narain, chief executive and co-founder of Veera Health.

She added that the platform has partnered with leading clinicians and researchers from across the world to develop the diagnostic protocol and has designed the test packages in a way that supplements the diagnostic protocol.